ReviewBritish journal of pharmacology2012

Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.

Thérèse Keravis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.